Literature DB >> 24900029

Effect of Animal Condition and Fluvoxamine on the Result of [(18)F]N-3-Fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) Nortropane ([(18)F]FP-CIT) PET Study in Mice.

Kwang-Ho Shin1, Su-A Park2, Seog-Young Kim3, Sang Ju Lee1, Seung Jun Oh1, Jae Seung Kim4.   

Abstract

PURPOSE: PET (positron emission tomography) is a noninvasive imaging technique, visualizing biological aspects in vivo. In animal models, the result of PET study can be affected more prominently than in humans by the animal conditions or drug pretreatment. We assessed the effects of anesthesia, body temperature, and pretreatment with selective serotonin reuptake inhibitor on the results of [(18)F]N-3-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) nortropane ([(18)F]FP-CIT) PET in mice.
METHODS: [(18)F]FP-CIT PET of C57BL/6 mice was performed in three different conditions: (1) anesthesia (isoflurane) with active warming (38°C) as a reference; (2) no anesthesia or warming; (3) anesthesia without warming at room temperature. Additional groups of mice pretreated with escalating doses of fluvoxamine (5, 20, 40, 80 mg/kg) were imaged in condition (1). The time activity curve and standardized uptake value of the striatum, cerebral cortex, and bone were compared among these conditions.
RESULTS: In all conditions, radioactivities of the striatum and cortex tended to form a plateau after rapid uptake and washout, but that of bone tended to increase gradually. When anesthetized without any warming, all the mice developed hypothermia and showed reduced bone uptake with slightly increased striatal and cortical uptakes compared to the reference condition. In conditions without anesthesia, striatal and cortical uptakes were reduced, whereas the bone uptake showed no change. Pretreatment with fluvoxamine increased the striatal uptake and striatal specific to cortical non-specific uptake ratio, whereas the bone uptake was reduced.
CONCLUSION: Anesthesia, body temperature, and fluvoxamine affect the result of [(18)F]FP-CIT PET in mice by altering striatal and bone uptakes.

Entities:  

Keywords:  Anesthesia; Fluvoxamine; Mice; PET; Temperature; [18F]FP-CIT

Year:  2011        PMID: 24900029      PMCID: PMC4042980          DOI: 10.1007/s13139-011-0117-5

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  32 in total

Review 1.  Molecular imaging of small animals with dedicated PET tomographs.

Authors:  Arion F Chatziioannou
Journal:  Eur J Nucl Med Mol Imaging       Date:  2001-11-22       Impact factor: 9.236

Review 2.  Use of positron emission tomography in animal research.

Authors:  S R Cherry; S S Gambhir
Journal:  ILAR J       Date:  2001

Review 3.  Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism.

Authors:  J Booij; G Tissingh; A Winogrodzka; E A van Royen
Journal:  Eur J Nucl Med       Date:  1999-02

Review 4.  Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design.

Authors:  C L DeVane; H S Gill
Journal:  J Clin Psychiatry       Date:  1997       Impact factor: 4.384

5.  [18F] beta-CIT-FP is superior to [11C] beta-CIT-FP for quantitation of the dopamine transporter.

Authors:  C Lundkvist; C Halldin; N Ginovart; C G Swahn; L Farde
Journal:  Nucl Med Biol       Date:  1997-10       Impact factor: 2.408

6.  Radiosynthesis of [18F] N-3-fluoropropyl-2-beta-carbomethoxy-3-beta-(4-iodophenyl) nortropane and the first human study with positron emission tomography.

Authors:  T Chaly; V Dhawan; K Kazumata; A Antonini; C Margouleff; J R Dahl; A Belakhlef; D Margouleff; A Yee; S Wang; G Tamagnan; J L Neumeyer; D Eidelberg
Journal:  Nucl Med Biol       Date:  1996-11       Impact factor: 2.408

7.  Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane.

Authors:  E D Kharasch; K E Thummel
Journal:  Anesthesiology       Date:  1993-10       Impact factor: 7.892

Review 8.  PET radiotracers: crossing the blood-brain barrier and surviving metabolism.

Authors:  Victor W Pike
Journal:  Trends Pharmacol Sci       Date:  2009-07-16       Impact factor: 14.819

9.  Interaction of isoflurane with the dopamine transporter.

Authors:  John Votaw; Michael Byas-Smith; Jian Hua; Ronald Voll; Laurent Martarello; Allan I Levey; F DuBois Bowman; Mark Goodman
Journal:  Anesthesiology       Date:  2003-02       Impact factor: 7.892

10.  N-(3-[18F]fluoropropyl)-spiperone: the preferred 18F labeled spiperone analog for positron emission tomographic studies of the dopamine receptor.

Authors:  M J Welch; J A Katzenellenbogen; C J Mathias; J W Brodack; K E Carlson; D Y Chi; C S Dence; M R Kilbourn; J S Perlmutter; M E Raichle
Journal:  Int J Rad Appl Instrum B       Date:  1988
View more
  2 in total

1.  The Effect of SSRIs on the Binding of (18)F-FP-CIT in Parkinson Patients: A Retrospective Case Control Study.

Authors:  Minjung Seo; Minyoung Oh; Minjung Cho; Sun Ju Chung; Chong Sik Lee; Jae Seung Kim
Journal:  Nucl Med Mol Imaging       Date:  2014-07-03

2.  Automated Analysis of (123)I-beta-CIT SPECT Images with Statistical Probabilistic Anatomical Mapping.

Authors:  Jae Seon Eo; Ho-Young Lee; Jae Sung Lee; Yu Kyung Kim; Bum-Seok Jeon; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2013-11-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.